menu
    • menu

    Company profile for Cour Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    To our knowledge, this is the first clinical trial to demonstrate induction of antigen specific immune tolerance in any autoimmune disease. COUR’s platform of immune-modifying nanoparticles treats the root cause of immune-mediated disease unlike traditional approaches, which rely on toxic immune suppressants or avoidance strategies. We are a group of dedicated scientific, medical, and business professionals who are driven to...
    To our knowledge, this is the first clinical trial to demonstrate induction of antigen specific immune tolerance in any autoimmune disease. COUR’s platform of immune-modifying nanoparticles treats the root cause of immune-mediated disease unlike traditional approaches, which rely on toxic immune suppressants or avoidance strategies. We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures of immune-mediated diseases. By focusing our research on the root cause of disease, we seek to provide treatments previously unavailable to doctors and their patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cour PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2215 Sanders Rd Northbrook, Illinois 60062
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://courpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cour-pharmaceutical-development-company-inc.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/courpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cour Pharma Gets Orphan Status For CNP-106 In Myasthenia Gravis
    Cour Pharma Gets Orphan Status For CNP-106 In Myasthenia Gravis

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159437/0/en/COUR-Pharma-Secures-FDA-Orphan-Drug-Designation-for-CNP-106-in-Generalized-Myasthenia-Gravis.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    COUR Pharma Begins Trial of CNP-103 in Type 1 Diabetes
    COUR Pharma Begins Trial of CNP-103 in Type 1 Diabetes

    19 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/19/3135630/0/en/COUR-Pharma-Doses-First-Patient-in-Clinical-Trial-Evaluating-CNP-103-in-People-Recently-Diagnosed-with-Type-1-Diabetes.html

    GLOBENEWSWIRE
    19 Aug 2025
    Share Share
    COUR Pharma Secures FDA Clearance for CNP-103 in Type 1 Diabetes
    COUR Pharma Secures FDA Clearance for CNP-103 in Type 1 Diabetes

    04 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/04/3020208/0/en/COUR-Pharmaceuticals-Secures-FDA-Clearance-of-IND-Application-for-CNP-103-in-Type-1-Diabetes.html

    GLOBENEWSWIRE
    04 Feb 2025
    Share Share
    COUR Pharma Gains FDA Orphan Drug Status For CNP-104 In PBC
    COUR Pharma Gains FDA Orphan Drug Status For CNP-104 In PBC

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006227/0/en/COUR-Pharmaceuticals-Secures-FDA-Orphan-Drug-Designation-for-CNP-104-in-Primary-Biliary-Cholangitis.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share
    Roche Partners With COUR in Autoimmune Deal Worth $900M
    Roche Partners With COUR in Autoimmune Deal Worth $900M

    04 Dec 2024

    // BIOSPACE

    https://www.biospace.com/business/roche-partners-with-cour-in-autoimmune-deal-potentially-worth-more-than-900m

    BIOSPACE
    04 Dec 2024
    Share Share
    COUR Signs Licensing Deal with Genentech for Autoimmune Therapy
    COUR Signs Licensing Deal with Genentech for Autoimmune Therapy

    03 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/03/2990410/0/en/COUR-Pharmaceuticals-Enters-Collaboration-and-Licensing-Agreement-with-Genentech-to-Develop-and-Commercialize-Tolerogenic-Therapy-for-the-Treatment-of-an-Autoimmune-Disease.html

    GLOBENEWSWIRE
    03 Dec 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search